Inventiva SA
LSE:0RNK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inventiva SA
LSE:0RNK
|
FR |
|
Spectur Ltd
ASX:SP3
|
AU |
|
Tubos Reunidos SA
F:TU1
|
ES |
|
Banco Bradesco SA
BOVESPA:BBDC4
|
BR |
|
U
|
United Rentals Inc
XMUN:UR3
|
US |
|
K
|
Kajima Corp
DUS:KAJ
|
JP |
|
I
|
Ingredion Inc
F:CNP
|
US |
Intrinsic Value
Is 0RNK undervalued or overvalued?
See the intrinsic value estimate for 
Inventiva SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Inventiva Does
Inventiva SA is a French biopharmaceutical company that develops oral drug candidates for serious liver and metabolic diseases, with a main focus on MASH, the fatty liver disease that can progress to inflammation and scarring. It also has work in rare diseases. The company is not a drug store or generic manufacturer; it is a research-and-development business that takes compounds through lab testing and clinical trials.
- Headquarters
- France FR
- Employees
- 73
- IPO date
- Feb 15, 2017
Earnings Waterfall
Inventiva SA
The intrinsic value for Inventiva SA (0RNK) under the Base Case is hidden EUR.
Compared with the current market price of 3.19 EUR, the stock appears hidden.